This study is currently not recruiting participants.

Project ECHO 200280 Study #DAKOS0009A

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The objective of the study is to establish a reasonable assurance of safety and effectiveness of HercepTest? mAb pharmDx as an aid in the assessment of breast cancer patients for whom Herceptin? (trastuzumab) PERJETA? (pertuzumab) or KADCYLA? (ado-trastuzumab emtansine) treatment is being considered.

Detailed description of study

The objective of the study is to establish a reasonable assurance of safety and effectiveness of HercepTest? mAb pharmDx as an aid in the assessment of breast cancer patients for whom Herceptin? (trastuzumab) PERJETA? (pertuzumab) or KADCYLA? (ado-trastuzumab emtansine) treatment is being considered.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: breast cancer
  • Age: 100 years or below
  • Gender: All
Updated on 30 Jul 2018. Study ID: 1807356811

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team